Streetbeat News

Products Services

SONY

Sony's May 2024 State of Play event unveiled 14 new games for PS5, PC, and PSVR2, including titles like Concord, God of War: Ragnarok, and Silent Hill 2 Remake. The event highlighted Sony's continued focus on expanding its gaming portfolio and leveraging its successful PS5 platform.

Portfolio Pulse from Franca Quarneti

May 31, 2024 | 7:10 pm

CRM

Salesforce Inc (NYSE:CRM) experienced a 20% stock drop after a disappointing quarter. Reddit users on r/stocks caution against buying the dip, citing slowing revenue growth, competition, management issues, dependency on interest rates, and limited growth potential. Concerns also include Salesforce's per-head fee structure and heavy advertising spend.

Portfolio Pulse from Surbhi Jain

May 31, 2024 | 6:53 pm

LRCX

Deep-pocketed investors are showing significant interest in Lam Research (NASDAQ:LRCX) options, with a notable split between bullish and bearish sentiments. The options activity suggests a price window between $610 and $1000. Lam Research is a major player in semiconductor wafer fabrication equipment, with key customers like TSMC, Samsung, Intel, and Micron. The stock is currently trading at $949.53, with a neutral RSI and an earnings announcement expected in 54 days.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 6:45 pm

SNAP

Traders are closely watching Snap Inc. as TikTok disputes a Reuters report claiming it is cloning its algorithm to offer a potentially degraded version of the app for U.S. users.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 6:30 pm

IONS

Ionis Pharmaceuticals announced positive Phase 3 results for donidalorsen in treating hereditary angioedema (HAE). The drug showed significant reductions in HAE attack rates and was well-tolerated. Ionis plans to seek FDA approval, and analysts see strong growth potential for the company.

Portfolio Pulse from Vandana Singh

May 31, 2024 | 6:25 pm

BMY

The FDA has expanded the approval of Bristol Myers Squibb's Breyanzi, a CAR T cell therapy, to include relapsed or refractory mantle cell lymphoma (MCL). This makes Breyanzi the CAR T cell therapy available for the broadest range of B-cell malignancies. The approval is based on positive results from the TRANSCEND NHL 001 trial.

Portfolio Pulse from Vandana Singh

May 31, 2024 | 6:14 pm

NVS

Novartis AG (NYSE:NVS) has filed a lawsuit to block a Maryland law requiring drugmakers to offer discounts on drugs dispensed by third-party pharmacies contracting with hospitals and clinics serving low-income populations. The law, set to take effect on July 1, conflicts with the federal 340B drug discount program. Novartis argues that the law attempts to regulate interstate commerce outside of Maryland and complicates recordkeeping and transparency.

Portfolio Pulse from Vandana Singh

May 31, 2024 | 6:12 pm

BA

Fitch has updated its forecasts for Boeing's aircraft deliveries, maintaining that Boeing could achieve a 737 MAX production rate in the low-30s by the end of 2024 and mid-30s by early 2025. Additionally, Boeing is expected to produce closer to three 787s per month during 2024, before increasing to five per month in 2025.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 6:10 pm

LLY

NVO

Novo Nordisk (NYSE:NVO) has filed lawsuits against nine additional U.S. clinics for selling fake semaglutide products, bringing the total to 21 lawsuits. Some products were found to be up to 33% impure. Eli Lilly (NYSE:LLY) has also taken legal action against clinics selling counterfeit tirzepatide products.

Portfolio Pulse from Vandana Singh

May 31, 2024 | 6:08 pm

FL

NKE

Foot Locker (NYSE:FL) reported better-than-expected comparable sales and adjusted earnings for its fiscal first quarter, indicating progress in its turnaround plan. The company also reaffirmed its full-year outlook, with expectations of growth in comparable sales and adjusted earnings per share. Foot Locker's efforts include revamping stores, enhancing its mobile app and rewards program, and strengthening its partnership with Nike (NYSE:NKE).

Portfolio Pulse from Upwallstreet

May 31, 2024 | 6:03 pm